SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ | Filed by a Party other than the Registrant ☐ | ||||
Check the appropriate box: | |||||
☐ Preliminary Proxy Statement | |||||
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||
☐ Definitive Proxy Statement | |||||
☒ Definitive Additional Materials | |||||
☐ Soliciting Material under 240.14a-12 | |||||
BELLICUM PHARMACEUTICALS, INC.
| (Name of Registrant as Specified In Its Charter) | ||||||||||||||
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant) | ||||||||||||||
| Payment of Filing Fee (check the appropriate box): | |||||
☒ No fee required. | |||||
☐ Fee paid previously with preliminary materials. | |||||
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||||
